참고문헌 (83)

1. Anand K. Palm G. J. Mesters J. R. Siddell S. G. Ziebuhr J. Hilgenfeld R. ( 2002 ). Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain . EMBO J. 21 , 3213 ？ 3224 . 10.1093/emboj/cdf327 12093723 

   상세보기

2. Anand K. Ziebuhr J. Wadhwani P. Mesters J. R. Hilgenfeld R. ( 2003 ). Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs . Science 300 , 1763 ？ 1767 . 10.1126/science.1085658 12746549 

   상세보기

3. Andersen K. G. Rambaut A. Lipkin W. I. Holmes E. C. Garry R. F. ( 2020 ). The proximal origin of SARS-CoV-2 . Nat. Med. 26 , 450 ？ 452 . 10.1038/s41591-020-0820-9 32284615 

   상세보기

4. Barnes C. O. West A. P. Jr. Huey-Tubman K. E. Hoffmann M. A. G. Sharaf N. G. Hoffman P. R. ( 2020 ). Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies . Cell . 10.1016/j.cell.2020.06.025 . [Epub ahead of print]. 

   상세보기

5. Belouzard S. Chu V. C. Whittaker G. R. ( 2009 ). Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites . Proc. Natl. Acad. Sci. U. S. A. 106 , 5871 ？ 5876 . 10.1073/pnas.0809524106 19321428 

   상세보기

6. Bittmann S. Luchter E. Weissenstein A. Villalon G. Moschuring-Alieva E. ( 2020 ). TMPRSS2-inhibitors play a role in cell entry mechanism of COVID-19: an insight into camostat and nafamostat . J. Regen. Biol. Med. 2 , 1 ？ 3 . 10.37191/Mapsci-2582-385X-2(2)-022 

   

7. Brierley I. Digard P. Inglis S. C. ( 1989 ). Characterization of an efficient coronavirus ribosomal frameshifting signal: requirement for an RNA pseudoknot . Cell 57 , 537 ？ 547 . 2720781 

   상세보기

8. Burchill L. J. Velkoska E. Dean R. G. Griggs K. Patel S. K. Burrell L. M. ( 2012 ). Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions . Clin. Sci. 123 , 649 ？ 658 . 10.1042/CS20120162 22715807 

   상세보기

9. Cascella M. Rajnik M. Cuomo A. Dulebohn S. C. Di Napoli R. ( 2020 ). “Features, evaluation and treatment coronavirus (COVID-19),” in Statpearls [internet] ( Treasure Island, FL : StatPearls ). 

10. Chen N. Zhou M. Dong X. Qu J. Gong F. Han Y. . ( 2020 ). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study . Lancet 395 , 507 ？ 513 . 10.1016/S0140-6736(20)30211-7 32007143 

    상세보기

11. Cheng Y.-S. Williamson P. R. Zheng W. ( 2019 ). Improving therapy of severe infections through drug repurposing of synergistic combinations . Curr. Opin. Pharmacol. 48 , 92 ？ 98 . 10.1016/j.coph.2019.07.006 31454708 

    상세보기

12. Dai W. Zhang B. Su H. Li J. Zhao Y. Xie X. . ( 2020 ). Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease . Science 368 , 1331 ？ 1335 . 10.1126/science.abb4489 32321856 

    상세보기

13. de Abajo F. J. Rodriguez-Martin S. Lerma V. Mejia-Abril G. Aguilar M. Garcia-Luque A. . ( 2020 ). Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study . Lancet 395 , 1705 ？ 1714 . 10.1016/S0140-6736(20)31030-8 32416785 

    상세보기

14. Elfiky A. A. ( 2020 ). Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 . Life Sci. 248 : 117477 . 10.1016/j.lfs.2020.117477 32119961 

    상세보기

15. Fang L. Karakiulakis G. Roth M. ( 2020 ). Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet. Respir. Med. 8 : e21 . 10.1016/S2213-2600(20)30116-8 32171062 

    상세보기

16. Ferrario C. M. Jessup J. Chappell M. C. Averill D. B. Brosnihan K. B. Tallant E. A. . ( 2005 ). Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 . Circulation 111 , 2605 ？ 2610 . 10.1161/CIRCULATIONAHA.104.510461 15897343 

    상세보기

17. Gao Y. Yan L. Huang Y. Liu F. Zhao Y. Cao L. ( 2020 ). Structure of the RNA-dependent RNA polymerase from COVID-19 virus . Science 368 , 779 ？ 782 . 10.1126/science.abb7498 32277040 

    상세보기

18. Gorbalenya A. E. Baker S. C. Baric R. S. de Groot R. J. Drosten C. Gulyaeva A. A. . ( 2020 ). The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 . Nat. Microbiol. 5 , 536 ？ 544 . 10.1038/s41564-020-0695-z 32123347 

    상세보기

19. Gorbalenya A. E. Enjuanes L. Ziebuhr J. Snijder E. J. ( 2006 ). Nidovirales: evolving the largest RNA virus genome . Virus Res. 117 , 17 ？ 37 . 10.1016/j.virusres.2006.01.017 16503362 

    상세보기

20. Harcourt B. H. Jukneliene D. Kanjanahaluethai A. Bechill J. Severson K. M. Smith C. M. . ( 2004 ). Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity . J. Virol. 78 , 13600 ？ 13612 . 10.1128/JVI.78.24.13600-13612.2004 15564471 

    상세보기

21. Harrison C. ( 2020 ). Coronavirus puts drug repurposing on the fast track . Nat. Biotechnol. 38 , 379 ？ 381 . 10.1038/d41587-020-00003-1 32205870 

    상세보기

22. Hegyi A. Ziebuhr J. ( 2002 ). Conservation of substrate specificities among coronavirus main proteases . J. Gen. Virol. 83 , 595 ？ 599 . 10.1099/0022-1317-83-3-595 11842254 

    상세보기

23. Herold J. Raabe T. Schelle-Prinz B. Siddell S. ( 1993 ). Nucleotide sequence of the human coronavirus 229E RNA polymerase locus . Virology 195 , 680 ？ 691 8337838 

    상세보기

24. Hoffmann M. Kleine-Weber H. Schroeder S. Kruger N. Herrler T. Erichsen S. . ( 2020 ). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor . Cell 181 : 271 ？ 280.e8 . 10.1016/j.cell.2020.02.052 32142651 

    상세보기

25. Hogue B. Machamer C. ( 2008 ). Nidoviruses . Washington, DC : ASM Press ) 

26. Holshue M. L. DeBolt C. Lindquist S. Lofy K. H. Wiesman J. Bruce H. ( 2020 ). First case of 2019 novel coronavirus in the United States . N. Engl. J. Med. 382 , 929 ？ 936 . 10.1056/NEJMoa2001191 32004427 

    상세보기

27. Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. . ( 2020 ). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China . Lancet 395 , 497 ？ 506 . 10.1016/S0140-6736(20)30183-5 31986264 

    상세보기

28. Huang J. Song W. Huang H. Sun Q. ( 2020 ). Pharmacological therapeutics targeting RNA-dependent RNA polymerase, proteinase and spike protein: from mechanistic studies to clinical trials for COVID-19 . J. Clin. Med. 9 : 1131 . 10.3390/jcm9041131 32326602 

    상세보기

29. Huentelman M. J. Zubcevic J. Hernandez Prada J. A. Xiao X. Dimitrov D. S. Raizada M. K. . ( 2004 ). Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor . Hypertension 44 , 903 ？ 906 . 10.1161/01.HYP.0000146120.29648.36 15492138 

    상세보기

30. Jankun J. ( 2020 ). COVID-19 pandemic; transmembrane protease serine 2 (TMPRSS2) inhibitors as potential drugs . Univ. Toledo J. Med. Sci. 7 , 1 ？ 5 . 10.46570/utjms.vol7-2020-361 

    상세보기

31. Jin Z. Du X. Xu Y. Deng Y. Liu M. Zhao Y. . ( 2020 ). Structure of M pro from COVID-19 virus and discovery of its inhibitors . Nature 582 , 289 ？ 293 . 10.1038/s41586-020-2223-y 32272481 

    상세보기

32. Ju B. Zhang Q. Ge J. Wang R. Sun J. Ge X. . ( 2020 ). Human neutralizing antibodies elicited by SARS-CoV-2 infection . Nature . 10.1038/s41586-020-2380-z . [Epub ahead of print]. 

    상세보기

33. Kirchdoerfer R. N. Ward A. B. ( 2019 ). Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors . Nat. Commun. 10 : 2342 . 10.1038/s41467-019-10280-3 31138817 

    상세보기

34. Klumperman J. Locker J. K. Meijer A. Horzinek M. C. Geuze H. J. Rottier P. ( 1994 ). Coronavirus M proteins accumulate in the golgi complex beyond the site of virion budding . J Virol. 68 , 6523 ？ 6534 . 8083990 

    상세보기

35. Lan J. Ge J. Yu J. Shan S. Zhou H. Fan S. . ( 2020 ). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor . Nature 581 , 215 ？ 220 . 10.1038/s41586-020-2180-5 32225176 

    상세보기

36. Lim L. Shi J. Mu Y. Song J. ( 2014 ). Dynamically-driven enhancement of the catalytic machinery of the SARS 3C-like protease by the S284-T285-I286/A mutations on the extra domain . PLoS ONE 9 : e101941 . 10.1371/journal.pone.0101941 25036652 

    상세보기

37. Liu H. Ye F. Sun Q. Liang H. Li C. Lu R. ( 2020 ). Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro. bioRxiv [Preprint] . 10.1101/2020.04.10.035824 

    

38. Lu R. Zhao X. Li J. Niu P. Yang B. Wu H. . ( 2020 ). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding . Lancet 395 , 565 ？ 574 . 10.1016/S0140-6736(20)30251-8 32007145 

    상세보기

39. Lv Z. Chu Y. Wang Y. ( 2015 ). HIV protease inhibitors: a review of molecular selectivity and toxicity . HIV AIDS 7 , 95 ？ 104 . 10.2147/HIV.S79956 25897264 

    상세보기

40. Matsuyama S. Nagata N. Shirato K. Kawase M. Takeda M. Taguchi F. ( 2010 ). Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2 . J. Virol. 84 , 12658 ？ 12664 . 10.1128/JVI.01542-10 20926566 

    상세보기

41. Matsuyama S. Nao N. Shirato K. Kawase M. Saito S. Takayama I. . ( 2020 ). Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells . Proc. Natl. Acad Sci. U.S.A. 117 , 7001 ？ 7003 . 10.1073/pnas.2002589117 32165541 

    상세보기

42. Monteil V. Kwon H. Prado P. Hagelkruys A. Wimmer R. A. Stahl M. . ( 2020 ). Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2 . Cell 181 , 905 ？ 913.e7 . 10.1016/j.cell.2020.04.004 32333836 

    상세보기

43. Pasternak A. O. Spaan W. J. Snijder E. J. ( 2006 ). Nidovirus transcription: how to make sense…? J. Gen. Virol. 87 , 1403 ？ 1421 . 10.1099/vir.0.81611-0 16690906 

    상세보기

44. Pinto D. Park Y.-J. Beltramello M. Walls A. C. Tortorici M. A. Bianchi S. . ( 2020 ). Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody . Nature 583 , 290 ？ 295 . 10.1038/s41586-020-2349-y 32422645 

    상세보기

45. Prentice E. McAuliffe J. Lu X. Subbarao K. Denison M. R. ( 2004 ). Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins . J. Virol. 78 , 9977 ？ 9986 . 10.1128/JVI.78.18.9977-9986.2004 15331731 

    상세보기

46. Raj V. S. Mou H. Smits S. L. Dekkers D. H. Muller M. A. Dijkman R. . ( 2013 ). Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC . Nature 495 , 251 ？ 254 . 10.1038/nature12005 23486063 

    상세보기

47. Sanders J. M. Monogue M. L. Jodlowski T. Z. Cutrell J. B. ( 2020 ). Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review . JAMA . 10.1001/jama.2020.6019 . [Epub ahead of print]. 

    

48. Sawicki S. G. Sawicki D. L. Siddell S. G. ( 2007 ). A contemporary view of coronavirus transcription . J. Virol. 81 , 20 ？ 29 . 10.1128/JVI.01358-06 16928755 

    상세보기

49. Schomburg K. T. Rarey M. ( 2014 ). What is the potential of structure-based target prediction methods? Future Med. Chem. 6 , 1987 ？ 1989 . 10.4155/fmc.14.135 25531963 

    상세보기

50. Senanayake S. L. ( 2020 ). Drug repurposing strategies for COVID-19 . Future Drug Discov 2 : FDD40 10.4155/fdd-2020-0010 

    상세보기

51. Shang J. Ye G. Shi K. Wan Y. Luo C. Aihara H. . ( 2020 ). Structural basis of receptor recognition by SARS-CoV-2 . Nature 10.1038/s41586-020-2179-y 32225175 

    상세보기

52. Sheahan T. P. Sims A. C. Zhou S. Graham R. L. Pruijssers A. J. Agostini M. L. . ( 2020 ). An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice . Sci. Transl. Med. 12 : eabb5883 . 10.1126/scitranslmed.abb5883 32253226 

    상세보기

53. Soler M. J. Ye M. Wysocki J. William J. Lloveras J. Batlle D. ( 2009 ). Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan . Am. J. Physiol. Renal. Physiol. 296 , F398 ？ 405 . 10.1152/ajprenal.90488.2008 19004932 

    상세보기

54. Sonawane K. Barale S. S. Dhanavade M. J. Waghmare S. R. Nadaf N. H. Kamble S. A. ( 2020 ). Homology modeling and docking studies of TMPRSS2 with experimentally known inhibitors Camostat mesylate, Nafamostat and Bromhexine hydrochloride to control SARS-Coronavirus-2 . ChemRxiv. 10.26434/chemrxiv.12162360.v1 

    

55. ter Meulen J. van den Brink E. N. Poon L. L. Marissen W. E. Leung C. S. Cox F. . ( 2006 ). Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants . PLoS Med. 3 : e237 . 10.1371/journal.pmed.0030237 16796401 

    상세보기

56. Thiel V. Herold J. Schelle B. Siddell S. G. ( 2001 ). Viral replicase gene products suffice for coronavirus discontinuous transcription . J. Virol. 75 , 6676 ？ 6681 . 10.1128/JVI.75.14.6676-6681.2001 11413334 

    상세보기

57. Thiel V. Ivanov K. A. Putics A. Hertzig T. Schelle B. Bayer S. . ( 2003 ). Mechanisms and enzymes involved in SARS coronavirus genome expression . J. Gen. Virol. 84 , 2305 ？ 2315 . 10.1099/vir.0.19424-0 12917450 

    상세보기

58. Tian X. Li C. Huang A. Xia S. Lu S. Shi Z. . ( 2020 ). Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody . Emerg. Microbes. Infect. 9 , 382 ？ 385 . 10.1080/22221751.2020.1729069 32065055 

    상세보기

59. Towler P. Staker B. Prasad S. G. Menon S. Tang J. Parsons T. . ( 2004 ). ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis . J. Biol. Chem. 279 , 17996 ？ 18007 . 10.1074/jbc.M311191200 14754895 

    상세보기

60. Vaduganathan M. Vardeny O. Michel T. McMurray J. J. V. Pfeffer M. A. Solomon S. D. ( 2020 ). Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19 . N. Engl. J. Med. 382 , 1653 ？ 1659 . 10.1056/NEJMsr2005760 32227760 

    상세보기

61. Venkataraman S. Prasad B. Selvarajan R. ( 2018 ). RNA dependent RNA polymerases: insights from structure, function and evolution . Viruses 10 : 76 . 10.3390/v10020076 29439438 

    상세보기

62. Walls A. C. Park Y.-J. Tortorici M. A. Wall A. McGuire A. T. Veesler D. ( 2020 ). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein . Cell 181 : 281 ？ 292.e6 . 10.1016/j.cell.2020.02.058 32155444 

    상세보기

63. Wang M. Cao R. Zhang L. Yang X. Liu J. Xu M. . ( 2020 ). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro . Cell Res. 30 , 269 ？ 271 . 10.1038/s41422-020-0282-0 32020029 

    상세보기

64. Wang Y. Zhang D. Du G. Du R. Zhao J. Jin Y. . ( 2020 ). Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial . Lancet 395 , P1569 ？ 1578 . 10.1016/S0140-6736(20)31022-9 32423584 

    상세보기

65. Warren T. K. Jordan R. Lo M. K. Ray A. S. Mackman R. L. Soloveva V. . ( 2016 ). Therapeutic efficacy of the small molecule GS-5734 against ebola virus in rhesus monkeys . Nature 531 , 381 ？ 385 . 10.1038/nature17180 26934220 

    상세보기

66. Watkins J. ( 2020 ). Preventing a covid-19 pandemic . BMJ 368 : m810 . 10.1136/bmj.m810 32111649 

    상세보기

67. Wrapp D. Wang N. Corbett K. S. Goldsmith J. A. Hsieh C. L. Abiona O. . ( 2020 ). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation . Science 367 , 1260 ？ 1263 . 10.1126/science.abb2507 32075877 

    상세보기

68. Wu Y. Wang F. Shen C. Peng W. Li D. Zhao C. . ( 2020 ). A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 . Science 368 , 1274 ？ 1278 . 10.1126/science.abc2241 32404477 

    상세보기

69. Xia S. Liu M. Wang C. Xu W. Lan Q. Feng S. . ( 2020 ). Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion . Cell Res. 30 , 343 ？ 355 . 10.1038/s41422-020-0305-x 32231345 

    상세보기

70. Xu X. Chen P. Wang J. Feng J. Zhou H. Li X. . ( 2020 ). Evolution of the novel coronavirus from the ongoing Wuhan Outbreak and modeling of its spike protein for risk of human transmission . Sci. China Life Sci. 63 , 457 ？ 460 . 10.1007/s11427-020-1637-5 32009228 

    상세보기

71. Yamamoto N. Matsuyama S. Hoshino T. Yamamoto N. ( 2020 ). Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro . bioRxiv . 10.1101/2020.04.06.026476 15144898 

    

72. Yan R. Zhang Y. Li Y. Xia L. Guo Y. Zhou Q. ( 2020 ). Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 . Science 367 , 1444 ？ 1448 . 10.1126/science.abb2762 32132184 

    상세보기

73. Yang H. Xie W. Xue X. Yang K. Ma J. Liang W. . ( 2005 ). Design of wide-spectrum inhibitors targeting coronavirus main proteases . PLoS Biol. 3 : e324 . 10.1371/journal.pbio.0030324 16128623 

    상세보기

74. Yin W. Mao C. Luan X. Shen D. D. Shen Q. Su H. . ( 2020 ). Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir . Science 368 , 1499 ？ 1504 . 10.1126/science.abc1560 32358203 

    상세보기

75. Yuan M. Wu N. C. Zhu X. Lee C.-C. D. So R. T. Lv H. . ( 2020 ). A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV . Science 368 , 630 ？ 633 . 10.1126/science.abb7269 32245784 

    상세보기

76. Zhai Y. Sun F. Li X. Pang H. Xu X. Bartlam M. . ( 2005 ). Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer . Nat. Struct. Mol. Biol. 12 , 980 ？ 986 . 10.1038/nsmb999 16228002 

    상세보기

77. Zhang L. Lin D. Kusov Y. Nian Y. Ma Q. Wang J. . ( 2020a ). α-ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment . J. Med. Chem . 63 , 4562 ？ 4578 . 10.1021/acs.jmedchem.9b01828 32045235 

    상세보기

78. Zhang L. Lin D. Sun X. Curth U. Drosten C. Sauerhering L. . ( 2020b ). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors . Science 368 , 409 ？ 412 . 10.1126/science.abb3405 32198291 

    상세보기

79. Zhou P. Yang X.-L. Wang X.-G. Hu B. Zhang L. Zhang W. . ( 2020 ). A pneumonia outbreak associated with a new coronavirus of probable bat origin . Nature 579 , 270 ？ 273 . 10.1038/s41586-020-2012-7 32015507 

    상세보기

80. Zhu N. Zhang D. Wang W. Li X. Yang B. Song J. . ( 2020 ). A novel coronavirus from patients with pneumonia in China, 2019 . N. Engl. J. Med. 382 , 727 ？ 733 . 10.1056/NEJMoa2001017 31978945 

    상세보기

81. Ziebuhr J. ( 2004 ). Molecular biology of severe acute respiratory syndrome coronavirus . Curr. Opin. Microbiol. 7 , 412 ？ 419 . 10.1016/j.mib.2004.06.007 15358261 

    상세보기

82. Ziebuhr J. Snijder E. J. Gorbalenya A. E. ( 2000 ). Virus-encoded proteinases and proteolytic processing in the Nidovirales . J. Gen. Virol. 81 , 853 ？ 879 . 10.1099/0022-1317-81-4-853 10725411 

    상세보기

83. Zumla A. Chan J. F. Azhar E. I. Hui D. S. Yuen K.-Y. ( 2016 ). Coronaviruses―drug discovery and therapeutic options . Nat. Rev Drug Discov. 15 , 327 ？ 347 . 10.1038/nrd.2015.37 26868298 

    상세보기

활용도 Top5 논문

더보기

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.